Skip to content
← Back to this collection

PUBLICATIONS · 16121218

Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Leukemia
Publication date
2005 Dec
First author
Perel Y

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Perel Y
      type
      Author
    2. name
      Auvrignon A
      type
      Author
    3. name
      Leblanc T
      type
      Author
    4. name
      Michel G
      type
      Author
    5. name
      Reguerre Y
      type
      Author
    6. name
      Vannier JP
      type
      Author
    7. name
      Dalle JH
      type
      Author
    8. name
      Gandemer V
      type
      Author
    9. name
      Schmitt C
      type
      Author
    10. name
      Méchinaud F
      type
      Author
    11. name
      Lejars O
      type
      Author
    12. name
      Piguet C
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Perel Y
      type
      Author
    2. name
      Auvrignon A
      type
      Author
    3. name
      Leblanc T
      type
      Author
    4. name
      Michel G
      type
      Author
    5. name
      Reguerre Y
      type
      Author
    6. name
      Vannier JP
      type
      Author
    7. name
      Dalle JH
      type
      Author
    8. name
      Gandemer V
      type
      Author
    9. name
      Schmitt C
      type
      Author
    10. name
      Méchinaud F
      type
      Author
    11. name
      Lejars O
      type
      Author
    12. name
      Piguet C
      type
      Author
    bibliography ids
    1. nci-bib-4b1b6d74c50244b1692c97d9
    book metadata
    content sha256
    3a97afb6bad89e644992b9a241ff3d43dbc18c433787559066fb79eb8342eb03
    document type
    citation
    dois
    1. 10.1038/sj.leu.2403867
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:16121218
    immutable id
    pubmed:16121218@3a97afb6bad89e644992b9a241ff3d43dbc18c433787559066fb79eb8342eb03
    journal
    abbreviation
    Leukemia
    issn electronic
    Source null
    issn print
    0887-6924
    issue
    12
    name
    Leukemia
    nlm unique id
    8704895
    pages
    2082-9
    volume
    19
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      16121218
      provenance
      batch id
      acd1a19ec1fd03e5b423
      provider
      NCBI PubMed ESummary
      record sha256
      430ea7eccea37fa893b408e98aa76c9a1b6ab52ebd56746c974fd0a44af2351f
      response sha256
      06f2789b1faf1384eea463ec33b6ace6458084d0e39588df6f3b23cecac27647
      retrieved at
      2026-09-09T23:46:01.895425+00:00
      publication date
      display
      2005 Dec
      precision
      month
      year
      2005
      publication types
      1. Journal Article
      2. Multicenter Study
      3. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/16121218/
      title
      Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group.

      Preserved source evidence · Not medical advice